INTRODUCTION
Rapid testing for identification of pathogens in bloodstream infections has the potential to provide crucial information that can improve patient care. There are a number of potential benefits to rapid pathogen identification, including decreased mortality from sepsis, more targeted diagnostic and therapeutic interventions, and more rapid optimization of antimicrobial therapy.
The Infectious Diseases Society of America has called for research on the impact of rapid diagnostic testing on the use of antimicrobials [1] . Studies in adults evaluating the clinical impact of rapid blood culture diagnostics on antimicrobial use have shown decreases in both the time to effective or optimal therapy and the reduction in the use of broad-spectrum agents [2] [3] [4] [5] [6] [7] [8] . Decreased use of broad-spectrum therapy for patients who can be treated with a more narrow-spectrum agent could reduce the incidence of adverse outcomes such as Clostridium difficile colitis or the emergence of resistant pathogens [9] [10] [11] . Studies evaluating the impact of rapid diagnostic methods for blood cultures in children are more limited. Initial studies focused primarily on the diagnostic accuracy and functionality of the tests [12] [13] [14] [15] [16] ;
however, more recent reports have shown benefits of rapid identification on overall antibiotic use in children [2, [17] [18] [19] [20] [21] [22] .
In adult studies, antimicrobial stewardship program (ASP) activities have proved to be a key component in effectively translating rapid diagnostics results into changes in patient care.
Prior pediatrics studies evaluating the impact of rapid blood culture diagnostics have had either limited formal ASP involvement [20, 21] or implemented stewardship simultaneously with the rapid diagnostic test [22] . Our institution has had an active ASP since 2010. Our ASP provides prospective audit and feedback guidance to providers regarding antimicrobial therapy. Three years after our ASP was started our institution sequentially implemented two rapid diagnostic platforms for pathogen identification in positive blood cultures over 2 years (2013) (2014) (2015) . First, a fluorescent in situ hybridization (PNA FISH) test targeting gram-positive organism was implemented, followed by a rapid multiplex PCR (rmPCR) with an expanded panel targeting both gram-positive and -negative pathogens that replaced most use of the PNA FISH. Our objective in this study was to evaluate the impact of these tests on time to organism identification in our hospital and to examine the impact of rapid testing on antibiotic use for specific pathogens in the setting of an established ASP.
METHODS
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Broad-Spectrum Gram-Negative Agents
For broad-spectrum gram-negative agents, we examined overall use as well as use specifically for children with blood cultures positive for gram-negative pathogens.
Outcome Measures and Statistical Analyses
The primary outcome measures were the time to organism identification and the use of select antimicrobial therapy as described above. 
RESULTS
Study Cohort
A total of 1419 bacteremic episodes were identified during the 3-year study period. Of these, 191 (13%) were polymicrobial and were excluded from analysis, leaving 1228 bacteremic episodes included in the study. The number of episodes analyzed in each time period was similar (397, 408, and 422 in the baseline, PNAFISH, and rmPCR periods, respectively). Demographic characteristics and site of treatment for included children were also similar and are shown in Table 1 . We found no significant differences between periods in length of stay (8, 7, and 9 days), 30-day mortality (4.3%, 4.2%, 3.5%), and 30-day representation to the emergency department or inpatient admission (39%, 40%, 44%) for the baseline, PNAFISH, and rmPCR periods, respectively.
Microbiology
Of 1228 first-positive blood cultures, 923 (75%)
were positive for gram-positive organisms, 280 (23%) were positive for gram-negative organisms, and 22 (2%) were positive for Candida species. The distribution of organisms was comparable in the three periods.
Specifically, the number of gram-negative Table 2 .
Time to Organism Identification
In the baseline period, the median time to organism identification from time 0 across all organisms was 23 h (IQR 16-31 h; Table 2 ). 
Broad-Spectrum Gram-Negative Antibiotics
In contrast to vancomycin, we found no difference between periods in the use of broad-spectrum gram-negative agents, including carbapenems. Overall, 22% of children with a positive blood culture received broad-spectrum gram-negative agents and 37% because their blood culture was positive for a gram-negative pathogen. Duration of therapy was also not statistically different between periods.
Overall mean duration of broad-spectrum gram-negative therapy was 28, 47 h if a gram-negative pathogen was identified.
Results are shown in Table 3 .
DISCUSSION
We evaluated the impact of two different rapid molecular diagnostics on the time to identification of organisms as well as select antibiotic prescribing for bloodstream pathogens in a children's hospital with a mature ASP. We found that the use of both PNA FISH and rmPCR significantly decreased the median time to identification of gram-positive organisms, and rmPCR also We did not find a reduction in the use of broad-spectrum gram-negative agents with the introduction of either PNAFISH or rmPCR.
Explanations of these findings include our should be performed to determine the economic value and cost-effectiveness of using these platforms. Despite these limitations, this is the largest study to our knowledge to evaluate the impact of rapid diagnostic testing on antibiotic prescribing for children with positive blood cultures and the first to our knowledge to evaluate two different rapid molecular methods with conventional culture-based methods over consecutive periods in the context of a mature ASP.
CONCLUSIONS
In conclusion, the introduction of rapid 
